| Online-Ressource |
Verfasst von: | Bauer, Timm [VerfasserIn]  |
| Zeymer, Uwe [VerfasserIn]  |
| Hochadel, Matthias [VerfasserIn]  |
| Zahn, Ralf [VerfasserIn]  |
| Gitt, Anselm Kai [VerfasserIn]  |
Titel: | Use and outcomes of multivessel percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock (from the EHS-PCI registry) |
Verf.angabe: | Timm Bauer, Uwe Zeymer, Matthias Hochadel, Helge Möllmann, Franz Weidinger, Ralf Zahn, Holger M. Nef, Christian W. Hamm, Jean Marco, and Anselm K. Gitt |
E-Jahr: | 2012 |
Jahr: | 1 April 2012 |
Umfang: | 6 S. |
Fussnoten: | Gesehen am 09.11.2018 |
Titel Quelle: | Enthalten in: The American journal of cardiology |
Ort Quelle: | Amsterdam [u.a.] : Elsevier, 1958 |
Jahr Quelle: | 2012 |
Band/Heft Quelle: | 109(2012), 7, Seite 941-946 |
ISSN Quelle: | 1879-1913 |
Abstract: | The value of multivessel percutaneous coronary intervention (MV-PCI) in patients with cardiogenic shock (CS) and multivessel disease (MVD) is still unclear because randomized controlled trials are missing. Therefore, we sought to evaluate the impact of MV-PCI on in-hospital outcomes of patients with MVD presenting with CS: 336 patients with acute myocardial infarction complicated by CS and ≥70% stenoses in ≥2 major epicardial vessels were included in this analysis of the Euro Heart Survey PCI registry. Patients undergoing MV-PCI (n = 82, 24%) were compared to those with single-vessel PCI (n = 254, 76%). The rate of 3-vessel disease (60% vs 57%, p = 0.63) was similar in the 2 cohorts. Presentation with resuscitation (48 vs 46%, p = 0.76) and ST-segment elevation myocardial infarction (83 vs 87%, p = 0.31) was frequent in patients with MV-PCI and single-vessel PCI. Patients with ventilation were more likely to receive MV-PCI (30% vs 19%, p = 0.05). There was a tendency toward a higher hospital mortality in patients with MV-PCI (48.8% vs 37.4%, p = 0.07). After adjustment for confounding variables, no significant difference for in-hospital mortality (odd ratio [OR] 1.28, 95% confidence interval [CI] 0.72 to 2.28) could be observed between the 2 groups. Age (OR 1.41, 95% CI 1.13 to 1.77), 3-vessel disease (OR 1.78, 95% CI 1.04 to 3.03), ventilation (OR 3.01, 95% CI 1.59 to 5.68), and previous resuscitation (OR 2.55, 95% CI 1.48 to 4.39) were independent predictors of hospital death. In conclusion, MV-PCI is currently used in only 1/4 of patients with CS and MVD. An additional nonculprit PCI was not associated with a survival benefit in these high risk patients. |
DOI: | doi:10.1016/j.amjcard.2011.11.020 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext ; Verlag: http://dx.doi.org/10.1016/j.amjcard.2011.11.020 |
| Volltext: http://www.sciencedirect.com/science/article/pii/S0002914911034369 |
| DOI: https://doi.org/10.1016/j.amjcard.2011.11.020 |
Datenträger: | Online-Ressource |
Sprache: | eng |
K10plus-PPN: | 1583128867 |
Verknüpfungen: | → Zeitschrift |
Use and outcomes of multivessel percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock (from the EHS-PCI registry) / Bauer, Timm [VerfasserIn]; 1 April 2012 (Online-Ressource)